Treatment of low-risk myelodysplastic syndromes with high-dose daily oral cholecalciferol (2000-4000 IU vitamin D3) [1]

I. Molnár; N. Stark; J. Lovato; B. L. Powell; J. Cruz; D. D. Hurd; J. S. Mathieu; T. C. Chen; M. F. Holick; S. Cambra; R. P. McQuellon; G. G. Schwartz

doi:10.1038/sj.leu.2404601

Treatment of low-risk myelodysplastic syndromes with high-dose daily oral cholecalciferol (2000-4000 IU vitamin D₃) [1]

I. Molnár, N. Stark, J. Lovato, B. L. Powell, J. Cruz, D. D. Hurd, J. S. Mathieu, T. C. Chen, M. F. Holick, S. Cambra, R. P. McQuellon, G. G. Schwartz

Great Plains IDeA-CTR

Research output: Contribution to journal › Letter

6 Scopus citations

Original language	English (US)
Pages (from-to)	1089-1092
Number of pages	4
Journal	Leukemia
Volume	21
Issue number	5
DOIs	https://doi.org/10.1038/sj.leu.2404601
State	Published - May 2007

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1038/sj.leu.2404601

Cite this

Molnár, I., Stark, N., Lovato, J., Powell, B. L., Cruz, J., Hurd, D. D., Mathieu, J. S., Chen, T. C., Holick, M. F., Cambra, S., McQuellon, R. P., & Schwartz, G. G. (2007). Treatment of low-risk myelodysplastic syndromes with high-dose daily oral cholecalciferol (2000-4000 IU vitamin D₃) [1]. Leukemia, 21(5), 1089-1092. https://doi.org/10.1038/sj.leu.2404601

Treatment of low-risk myelodysplastic syndromes with high-dose daily oral cholecalciferol (2000-4000 IU vitamin D₃) [1]. / Molnár, I.; Stark, N.; Lovato, J.; Powell, B. L.; Cruz, J.; Hurd, D. D.; Mathieu, J. S.; Chen, T. C.; Holick, M. F.; Cambra, S.; McQuellon, R. P.; Schwartz, G. G.

In: Leukemia, Vol. 21, No. 5, 05.2007, p. 1089-1092.

Research output: Contribution to journal › Letter

@article{07fa1102572a47c6880df202f297277d,

title = "Treatment of low-risk myelodysplastic syndromes with high-dose daily oral cholecalciferol (2000-4000 IU vitamin D3) [1]",

author = "I. Moln{\'a}r and N. Stark and J. Lovato and Powell, {B. L.} and J. Cruz and Hurd, {D. D.} and Mathieu, {J. S.} and Chen, {T. C.} and Holick, {M. F.} and S. Cambra and McQuellon, {R. P.} and Schwartz, {G. G.}",

year = "2007",

month = may,

doi = "10.1038/sj.leu.2404601",

language = "English (US)",

volume = "21",

pages = "1089--1092",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "5",

}

TY - JOUR

T1 - Treatment of low-risk myelodysplastic syndromes with high-dose daily oral cholecalciferol (2000-4000 IU vitamin D3) [1]

AU - Molnár, I.

AU - Stark, N.

AU - Lovato, J.

AU - Powell, B. L.

AU - Cruz, J.

AU - Hurd, D. D.

AU - Mathieu, J. S.

AU - Chen, T. C.

AU - Holick, M. F.

AU - Cambra, S.

AU - McQuellon, R. P.

AU - Schwartz, G. G.

PY - 2007/5

Y1 - 2007/5

UR - http://www.scopus.com/inward/record.url?scp=34247644442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247644442&partnerID=8YFLogxK

U2 - 10.1038/sj.leu.2404601

DO - 10.1038/sj.leu.2404601

M3 - Letter

C2 - 17344922

AN - SCOPUS:34247644442

VL - 21

SP - 1089

EP - 1092

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 5

ER -